# Uterine PEComa With Lymphangioleiomyomatosis (LAM)‐Like Features: A Case Report

**Authors:** Ramani Raman, Daisy Maharjan, Carina Dehner, Sheila Segura

PMC · DOI: 10.1155/crip/1620175 · Case Reports in Pathology · 2026-02-25

## TL;DR

A rare uterine tumor resembling lymphangioleiomyomatosis was diagnosed in a 58-year-old woman using a combination of imaging, biopsy, and genetic testing.

## Contribution

This case report provides a detailed diagnosis of uterine PEComa with LAM-like features using integrated morphological and molecular methods.

## Key findings

- The tumor was positive for HMB45, desmin, and Cathepsin K, and had a TSC1 variant.
- The patient showed no metastatic disease after surgery and follow-up.
- Integrated assessment is crucial for accurate diagnosis of uterine mesenchymal neoplasms.

## Abstract

Perivascular epithelioid cell tumors (PEComas) of the uterus are rare mesenchymal neoplasms characterized by myogenic and melanocytic differentiation. These tumors can mimic other uterine mesenchymal tumors in their clinical presentation and morphology. We report a case of a 58‐year‐old woman who presented with abnormal uterine bleeding. Initial imaging revealed an endometrial polyp, which was later diagnosed as a leiomyoma on excision biopsy. A subsequent hysterectomy with bilateral salpingectomy revealed a uterine neoplasm composed of spindled to epithelioid cells with low‐grade cytologic atypia, infiltrative edges, and extensive lymphovascular invasions, initially suggestive of low‐grade endometrial stromal sarcoma. However, immunohistochemical stains demonstrated tumor positivity for HMB45, desmin, and Cathepsin K, and genetic testing revealed a TSC1 variant, leading to a definite diagnosis of uterine PEComa with lymphangioleiomyomatosis (LAM)‐like features. The patient′s postoperative course was uneventful, and follow‐up imaging showed no evidence of metastatic disease. This case highlights the importance of integrated morphological, immunohistochemical, and molecular assessment in differentiating uterine mesenchymal neoplasms to guide appropriate clinical management.

## Linked entities

- **Genes:** TSC1 (TSC complex subunit 1) [NCBI Gene 7248]
- **Proteins:** PMEL (premelanosome protein), LOC101066771 (desmin-like)
- **Diseases:** lymphangioleiomyomatosis (MONDO:0006277), PEComa (MONDO:0006359), leiomyoma (MONDO:0001572), endometrial stromal sarcoma (MONDO:0006745)

## Full-text entities

- **Genes:** TYR (tyrosinase) [NCBI Gene 7299] {aka ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3}, TFE3 (transcription factor binding to IGHM enhancer 3) [NCBI Gene 7030] {aka MRXSPF, RCCP2, RCCX1, TFEA, bHLHe33}, CD34 (CD34 molecule) [NCBI Gene 947], SMN1 (survival of motor neuron 1, telomeric) [NCBI Gene 6606] {aka BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3}, CTSK (cathepsin K) [NCBI Gene 1513] {aka CTS02, CTSO, CTSO1, CTSO2, PKND, PYCD}, MITF (melanocyte inducing transcription factor) [NCBI Gene 4286] {aka CMM8, COMMAD, MI, MITF-A, WS2, WS2A}, SOX10 (SRY-box transcription factor 10) [NCBI Gene 6663] {aka DOM, PCWH, SOX-10, WS2E, WS4, WS4C}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, TSC2 (TSC complex subunit 2) [NCBI Gene 7249] {aka LAM, PPP1R160, TSC4}, CSNK1D (casein kinase 1 delta) [NCBI Gene 1453] {aka ASPS, CKI-delta, CKId, CKIdelta, FASPS2, HCKID}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, AR (androgen receptor) [NCBI Gene 367] {aka AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1}, FH (fumarate hydratase) [NCBI Gene 2271] {aka FMRD, HLRCC, HsFH, LRCC, MCL, MCUL1}, DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, TSC1 (TSC complex subunit 1) [NCBI Gene 7248] {aka LAM, TSC}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, MLANA (melan-A) [NCBI Gene 2315] {aka MART-1, MART1}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, CALD1 (caldesmon 1) [NCBI Gene 800] {aka CDM, H-CAD, HCAD, L-CAD, LCAD, NAG22}, RAD51B (RAD51 paralog B) [NCBI Gene 5890] {aka R51H2, RAD51L1, REC2}
- **Diseases:** uterine mesenchymal tumors (MESH:C535700), bleeding (MESH:D006470), uterine sarcomas (MESH:D012509), AML (MESH:D018207), melanoma (MESH:D008545), epithelioid leiomyosarcoma (MESH:D007890), alveolar soft part sarcoma (MESH:D018234), adnexal masses (MESH:D000291), Cancer (MESH:D009369), uterine mesenchymal neoplasms (MESH:D014594), tumor of the lung (MESH:D008175), skeletal (MESH:C564967), LG-ESS (MESH:D036821), PEComa (MESH:D054973), endometrial stromal sarcoma (MESH:D018203), polyps (MESH:D011127), endometrial polyp (MESH:D014591), fibroids (MESH:D007889), LVI (MESH:D009361), TSC (MESH:D014402), Smooth muscle tumors (MESH:D018235), necrosis (MESH:D009336), pelvic pain (MESH:D017699), sugar (MESH:D007787), metastases (MESH:D009362), uterine bleeding (MESH:D014592), LAM (MESH:D018192), anemia (MESH:D000740), Female Genital Tumors (MESH:D005833)
- **Chemicals:** tyrosine (MESH:D014443), paraffin (MESH:D010232), sirolimus (MESH:D020123), melanin (MESH:D008543)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** p.D546fs, c.1637_1657del17

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933633/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12933633/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933633/full.md

---
Source: https://tomesphere.com/paper/PMC12933633